Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice
- PMID: 14724829
- DOI: 10.1053/j.gastro.2003.08.031
Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice
Abstract
Background & aims: Indoleamine 2,3-dioxygenase (IDO), an interferon gamma-induced intracellular enzyme, inhibits lymphocyte proliferation through tryptophan degradation. IDO is highly expressed in the mammalian intestine. We sought to determine whether IDO played a regulatory role in the T-cell helper 1 (Th1)-mediated trinitrobenzene sulfonic acid (TNBS) model of colitis.
Methods: Intrarectal TNBS was given to SJL/J mice along with either placebo or a specific IDO inhibitor. IDO protein and mRNA expression were assessed by Western blotting and real-time PCR. Colonic lamina propria mononuclear cells (LPMNCs) were isolated, fractionated, and cultured, in the presence and absence of IFN-gamma, to determine the cell type(s) expressing IDO.
Results: IDO is expressed by professional antigen-presenting cells in the lamina propria. Induction of TNBS colitis resulted in a significant increase in IDO mRNA (P = 0.005) and protein expression. IDO inhibition during TNBS colitis resulted in an 80% mortality compared with 10% for placebo-treated animals (P = 0.0089). IDO inhibition resulted in a more severe colitis both histologically and morphologically (P < 0.05) and significantly increased colonic proinflammatory cytokine expression compared with placebo-treated animals.
Conclusions: IDO is expressed in the normal colon and is up-regulated in the setting of TNBS colitis. Inhibition of IDO during TNBS colitis resulted in increased mortality and an augmentation of the normal inflammatory response. These findings suggest that IDO plays an important role in the down-regulation of Th1 responses within the gastrointestinal tract.
Similar articles
-
Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.J Immunol. 2010 Apr 1;184(7):3907-16. doi: 10.4049/jimmunol.0900291. Epub 2010 Feb 24. J Immunol. 2010. PMID: 20181893 Free PMC article.
-
Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.J Cell Physiol. 1998 Oct;177(1):174-86. doi: 10.1002/(SICI)1097-4652(199810)177:1<174::AID-JCP18>3.0.CO;2-D. J Cell Physiol. 1998. PMID: 9731757
-
IDO1 plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice.J Immunol. 2013 Sep 15;191(6):3057-64. doi: 10.4049/jimmunol.1203306. Epub 2013 Aug 16. J Immunol. 2013. PMID: 23956437
-
Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy.J Reprod Immunol. 2002 Oct-Nov;57(1-2):143-50. doi: 10.1016/s0165-0378(02)00040-2. J Reprod Immunol. 2002. PMID: 12385839 Review.
-
Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses.J Reprod Immunol. 2001 Oct-Nov;52(1-2):5-13. doi: 10.1016/s0165-0378(01)00118-8. J Reprod Immunol. 2001. PMID: 11600174 Review.
Cited by
-
Generation of immunogenic and tolerogenic clinical-grade dendritic cells.Immunol Res. 2011 Dec;51(2-3):153-60. doi: 10.1007/s12026-011-8255-5. Immunol Res. 2011. PMID: 22105838 Free PMC article. Review.
-
Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase.Cancer Biol Ther. 2011 Dec 15;12(12):1050-8. doi: 10.4161/cbt.12.12.18142. Epub 2011 Dec 15. Cancer Biol Ther. 2011. PMID: 22157149 Free PMC article.
-
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.Blood. 2009 Dec 3;114(24):5062-70. doi: 10.1182/blood-2009-06-227587. Epub 2009 Oct 14. Blood. 2009. PMID: 19828695 Free PMC article.
-
Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.J Immunol. 2010 Apr 1;184(7):3907-16. doi: 10.4049/jimmunol.0900291. Epub 2010 Feb 24. J Immunol. 2010. PMID: 20181893 Free PMC article.
-
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18619-24. doi: 10.1073/pnas.0709261104. Epub 2007 Nov 14. Proc Natl Acad Sci U S A. 2007. PMID: 18003900 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials